Akari Therapeutics, Plc Operating Leases, Future Minimum Payments, Due Thereafter
Akari Therapeutics, Plc (AKTX) had Operating Leases, Future Minimum Payments, Due Thereafter of $225.00 thousand as of 2015-06-30, per its 10-Q filed 2015-08-12.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter · last filed 2015-08-12
- 2015-06-30: Operating Leases, Future Minimum Payments, Due Thereafter $225.00K.
- 2015-03-31: Operating Leases, Future Minimum Payments, Due Thereafter $225.00K.
- 2014-12-31: Operating Leases, Future Minimum Payments, Due Thereafter $225.00K.
| Period end | Operating Leases, Future Minimum Payments, Due Thereafter |
|---|---|
| 2015-06-30 | $225.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $225.00K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $225.00K 10-K · filed 2015-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |